Browsing by Author Tognela, Annette

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2015Estimation of an optimal chemotherapy utilization rate for malignant pleural mesothelioma: An evidence-based benchmark for cancer careClarke, Stephen; Kao, Steven; van Zandwijk, Nico; Vardy, Janette; Lumba, Sumit; Ng, Weng; Tognela, Annette; Northern Clinical School: Kolling Institute; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicineEstimation of an optimal chemotherapy utilization rate for malignant pleural mesothelioma: An evidence-based benchmark for cancer care, Asia-Pacific Journal of Clinical Oncology, vol.11, N/A, 2015,pp 85-92
2015A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trialBoyer, Michael; Chan, Matthew; Chinchen, Sarah; Coskinas, Xanthi; Espinoza, David; Pavlakis, Nick; Stockler, Martin; Tognela, Annette; Veillard, Anne-Sophie; Abdi, E; Begbie, S; Boyce, Adam; Briscoe, Karen; Crombie, C.; Davidson, A; et al, Various; Huighes, B G M; Lewis, C R; Long, J; Varma, S; Central Clinical School: Medicine; Northern Clinical School: Melanoma Institute of Australia; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreA phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial, Annals of Oncology, vol.26, 11, 2015,pp 2280-2286
2015Small HER2-positive breast cancer: Should size affect adjuvant treatment?Beith, Jane; Kiely, Belinda Emma; Bastick, Patricia; Descallar, Joseph; Lynch, Jodi; Mok, Kelly; Tognela, Annette; Central Clinical School: Medicine; NH&MRC Clinical Trials CentreSmall HER2-positive breast cancer: Should size affect adjuvant treatment?, Clinical Breast Cancer, vol.15, 4, 2015,pp 277-284